Amneal Pharmaceuticals, Inc. (2DT)
Munich
Closed
Oct 7, 2026
Day's Range
18.0052 wk Range
8.45Overview - 2DT - Amneal Pharmaceuticals, Inc.
Key Statistics
Valuation
Enterprise Value
2.40B
P/E (Trailing)
‪77.39‬
PEG Ratio
‪0.49‬
Price / Book
‪172.04‬
EV / EBITDA
‪3.96‬
Profitability
Gross Margin
‪42.01%‬
Profit Margin
‪36.87%‬
Operating Margin
‪12.59%‬
Return on Assets
‪1.95%‬
Return on Equity
‪-101.02%‬
Ownership
Shares Outstanding
319.33M
Price stats
50-Day Avg
‪15.71‬
200-Day Avg
‪12.83‬
Peers - 2DT - Amneal Pharmaceuticals, Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on Munich.
- 2DTMunichAmneal Pharmaceuticals, Inc.+53.09%52-week change77.39P/E (Trailing)‪36.87%‬Profit Margin
- 3KFMunichAuxly Cannabis Group Inc.+95.03%52-week change5.14P/E (Trailing)‪57.26%‬Profit Margin
- HLSMunichAIC Mines Limited+60.37%52-week change—P/E (Trailing)—Profit Margin
- PA8MunichPaion AG+72.36%52-week change-0.77P/E (Trailing)‪94.10%‬Profit Margin
- I76MunichIronwood Pharmaceuticals, Inc. Class A Common Stock+62.57%52-week change23.87P/E (Trailing)—Profit Margin
- NGQ1MunichMedicure Inc.+60.89%52-week change-2.63P/E (Trailing)‪40.71%‬Profit Margin
- E7PMunichIndivior Pharmaceuticals, Inc.+55.35%52-week change18.93P/E (Trailing)‪80.14%‬Profit Margin
Profile Summary - 2DT - Amneal Pharmaceuticals, Inc.
About
Amneal Pharmaceuticals, Inc. is a global biopharmaceutical company that develops, manufactures, markets, and distributes a broad portfolio of essential medicines. Its current business centers on generics, injectables, biosimilars, and specialty branded pharmaceutical products, serving patients and healthcare providers…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
